See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Aug. 29, 2006

Crohn's Disease Psoriasis and Psoriatic Disorders Post-Menopausal Osteoporosis

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Crohn's Disease

This study will evaluate Humira, an investigational human antibody, in people with Crohn's disease. Volunteers 18-75 who have moderate-to-severe active Crohn's, have stopped taking Remicade, and have not been treated with Humira (adalimumab) previously may qualify.

The research site is in Beachwood, Ohio.

More information

Please see http://www.centerwatch.com/patient/studies/cat51.html.

-----

Psoriasis and Psoriatic Disorders

This study for people with mild-to-moderate psoriasis will evaluate treating the condition with pritopic cream. Otherwise healthy volunteers with mild-to-moderate psoriasis and who are not pregnant may be eligible.

The research site is in Seattle, Wash.

More information

Please see http://www.centerwatch.com/patient/studies/cat126.html.

-----

Post-Menopausal Osteoporosis

This is a research study for women at risk of osteoporosis. Healthy post-menopausal women between 50 and 85 with below-normal bone density who have had a bone fracture or have family history of osteoporosis may be included. Two overnight stays are required and candidates may be compensated up to $800 for time and travel.

The research site is in Bingham Farms, Mich.

More information

Please see http://www.centerwatch.com/patient/studies/cat679.html.

-----

Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.